These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 27748629

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
    Mañosa M, Domènech E, Marín L, Olivé A, Zabana Y, Cabré E, Gassull MA.
    Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
    Benucci M, Nenci G, Cappelletti C, Manfredi M.
    Recenti Prog Med; 2008 Apr; 99(7-8):363-6. PubMed ID: 18751615
    [Abstract] [Full Text] [Related]

  • 35. Optimizing biological therapy in Crohn's disease.
    Gecse KB, Végh Z, Lakatos PL.
    Expert Rev Gastroenterol Hepatol; 2016 Apr; 10(1):37-45. PubMed ID: 26471077
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Infliximab-induced discoid lupus erythematosus.
    Cemil BC, Atas H, Canpolat F, Akca Y, Sasmaz R.
    Lupus; 2013 Apr; 22(5):515-8. PubMed ID: 23554040
    [Abstract] [Full Text] [Related]

  • 38. Certolizumab pegol for the management of Crohn's disease in adults.
    Rivkin A.
    Clin Ther; 2009 Jun; 31(6):1158-76. PubMed ID: 19695385
    [Abstract] [Full Text] [Related]

  • 39. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.
    Subramanian S, Yajnik V, Sands BE, Cullen G, Korzenik JR.
    Inflamm Bowel Dis; 2011 Jan; 17(1):99-104. PubMed ID: 20629183
    [Abstract] [Full Text] [Related]

  • 40. Anti-TNF-α-induced lupus syndrome : Two case reports and review of current literature.
    Sieiro Santos C, Álvarez Castro C, Moriano Morales C, Díez Álvarez E.
    Z Rheumatol; 2021 Jun; 80(5):481-486. PubMed ID: 33709168
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.